tradingkey.logo

Danaher Corp

DHR
查看詳細走勢圖
219.620USD
-4.920-2.19%
收盤 01/29, 16:00美東報價延遲15分鐘
155.25B總市值
43.31本益比TTM

Danaher Corp

219.620
-4.920-2.19%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-2.19%

5天

-8.52%

1月

-4.77%

6月

+6.17%

今年開始到現在

-4.06%

1年

-1.84%

查看詳細走勢圖

TradingKey Danaher Corp股票評分

單位: USD 更新時間: 2026-01-29

操作建議

Danaher Corp當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名47/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為262.15。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Danaher Corp評分

相關信息

行業排名
47 / 205
全市場排名
138 / 4540
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Danaher Corp亮點

亮點風險
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
高分紅
公司屬於高分紅公司,最新股息支付率20.13%
穩定分紅
公司5年內持續分紅,最新股息支付率20.13%
估值合理
公司最新PE估值43.31,處於3年歷史合理位
機構加倉
最新機構持股600.67M股,環比增加0.00%
大衛赫羅持倉
明星投資者大衛赫羅持倉,最新持倉3.32K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.06

分析師目標

基於 27 分析師
買入
評級
262.146
目標均價
+11.20%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Danaher Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Danaher Corp簡介

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
公司代碼DHR
公司Danaher Corp
CEOBlair (Rainer M)
網址https://www.danaher.com/
KeyAI